• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲基麦角新碱,麦角异胺的一种活性代谢产物。

Methylergometrine, an active metabolite of methysergide.

作者信息

Müller-Schweinitzer E, Tapparelli C

出版信息

Cephalalgia. 1986 Mar;6(1):35-41. doi: 10.1046/j.1468-2982.1986.0601035.x.

DOI:10.1046/j.1468-2982.1986.0601035.x
PMID:3698092
Abstract

In conscious dogs methysergide (MS) caused constriction of the saphenous vein at about 3000 times lower doses than methylergometrine (MT) when infused locally, but it elicited only a short-lasting venoconstrictor response when injected systemically intravenously. MS and MT proved to be equally active venoconstrictor agents when administered orally. Analysis of canine plasma by high-performance liquid chromatography showed that after both oral and intravenous administration of MS large amounts of MT appeared in the plasma, whereas only low and transient levels of MS could be detected. It is suggested that one of the first steps in metabolism of MS is demethylation at position 1 of the indole, leading to the formation of MT, which may be a main active principle of the therapeutic effectiveness of MS in the interval treatment of migraine headache.

摘要

在清醒犬中,当局部输注时,麦角新碱(MS)引起隐静脉收缩的剂量比甲基麦角新碱(MT)低约3000倍,但静脉内全身注射时仅引起短暂的静脉收缩反应。口服时,MS和MT被证明是同等活性的静脉收缩剂。通过高效液相色谱法分析犬血浆表明,口服和静脉注射MS后,血浆中均出现大量MT,而仅能检测到低水平且短暂的MS。提示MS代谢的第一步之一是吲哚1位去甲基化,导致MT形成,这可能是MS在偏头痛间歇性治疗中发挥治疗效果的主要活性成分。

相似文献

1
Methylergometrine, an active metabolite of methysergide.甲基麦角新碱,麦角异胺的一种活性代谢产物。
Cephalalgia. 1986 Mar;6(1):35-41. doi: 10.1046/j.1468-2982.1986.0601035.x.
2
Pharmacokinetics of methysergide and its metabolite methylergometrine in man.甲基麦角新碱及其代谢产物甲基麦角新碱在人体中的药代动力学。
Eur J Clin Pharmacol. 1986;30(1):75-7. doi: 10.1007/BF00614199.
3
Pharmacokinetics of methysergide and its metabolite methylergometrine in the rat.麦角新碱及其代谢产物甲基麦角新碱在大鼠体内的药代动力学
Drug Metab Dispos. 1990 May-Jun;18(3):338-43.
4
Pharmacodynamics and pharmacokinetics of dihydroergotamine (DHE) in conscious beagle dogs.
Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(1-2):162-5.
5
Methylergometrine antagonizes 5 HT in the temporal artery.甲基麦角新碱可拮抗颞动脉中的5-羟色胺。
Eur J Clin Pharmacol. 1987;33(1):77-9. doi: 10.1007/BF00610384.
6
Recording of the saphenous vein compliance by an ultrasonic echo-tracking device in the dog: effects of S 18149.利用超声回声跟踪装置记录犬隐静脉顺应性:S 18149的作用
Br J Pharmacol. 1997 Dec;122(7):1361-6. doi: 10.1038/sj.bjp.0701526.
7
Distribution of methylergometrine in the breast milk of dogs.甲基麦角新碱在犬母乳中的分布。
Eur J Drug Metab Pharmacokinet. 1980;5(1):21-4. doi: 10.1007/BF03189438.
8
Pharmacokinetics of methylergometrine (methylergonovine) in the rabbit and man.甲基麦角新碱(甲基麦角新碱)在兔和人体中的药代动力学。
Acta Pharmacol Toxicol (Copenh). 1977 May;40(5):561-9.
9
Methylergometrine (methylergonovine) concentrations in the human plasma and urine.
Int J Clin Pharmacol Biopharm. 1978 Jun;16(6):254-7.
10
Clinical pharmacokinetics of methylergometrine (methylergonovine).甲基麦角新碱(甲基麦角新碱)的临床药代动力学。
Int J Clin Pharmacol Ther Toxicol. 1981 Sep;19(9):386-91.

引用本文的文献

1
Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).1-酰基取代的二乙酰胺麦角酸(LSD)衍生物的药理学和生物转化研究。
Neuropharmacology. 2020 Aug 1;172:107856. doi: 10.1016/j.neuropharm.2019.107856. Epub 2019 Nov 19.
2
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).麦角酰胺类药物的回归。第一部分:1-丙酰基-d-麦角酸二乙酰胺(1P-LSD)的分析与行为特征
Drug Test Anal. 2016 Sep;8(9):891-902. doi: 10.1002/dta.1884. Epub 2015 Oct 12.
3
Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study.
静脉注射麦角乙脲治疗急诊就诊偏头痛女性患者的疗效和耐受性:一项开放标签的初步研究。
Head Face Med. 2009 Nov 8;5:21. doi: 10.1186/1746-160X-5-21.
4
Clinical pharmacology, physiology and pathophysiology of superficial veins--2.浅静脉的临床药理学、生理学及病理生理学——2.
Br J Clin Pharmacol. 1994 Oct;38(4):289-305. doi: 10.1111/j.1365-2125.1994.tb04357.x.
5
Methylergometrine antagonizes 5 HT in the temporal artery.甲基麦角新碱可拮抗颞动脉中的5-羟色胺。
Eur J Clin Pharmacol. 1987;33(1):77-9. doi: 10.1007/BF00610384.
6
Pharmacokinetics of methylergometrine in the rat: evidence for enterohepatic recirculation by a linked-rat model.甲基麦角新碱在大鼠体内的药代动力学:通过联体大鼠模型对肠肝循环的证据
Pharm Res. 1990 Jan;7(1):14-20. doi: 10.1023/a:1015871122537.
7
Actions of non-peptide ergot alkaloids at 5-HT1-like and 5-HT2 receptors mediating vascular smooth muscle contraction.非肽类麦角生物碱对介导血管平滑肌收缩的5-HT1样受体和5-HT2受体的作用。
Naunyn Schmiedebergs Arch Pharmacol. 1990 Aug;342(2):120-9. doi: 10.1007/BF00166953.
8
5-HT2 receptor antagonists and migraine therapy.5-羟色胺2受体拮抗剂与偏头痛治疗
J Neurol. 1991;238 Suppl 1:S45-52. doi: 10.1007/BF01642906.